Previous 10 | Next 10 |
2023-05-16 18:49:10 ET Summary Plenty of initiatives are afoot in Senseonics to grow the business and open up access to Eversense in a significant way. The market though remains unconvinced. Better sales growth is needed to really move the needle here. The company is still not...
2023-05-09 18:36:08 ET Senseonics Holdings, Inc. (SENS) Q2 2023 Earnings Conference Call May 9, 2023, 04:30 PM ET Company Participants Philip Taylor - IR Tim Goodnow - President and CEO Rick Sullivan - CFO Mukul Jain - COO Conference Call Participants ...
2023-05-09 16:23:05 ET Senseonics press release ( NYSE: SENS ): Q1 GAAP EPS of $0.00 beats by $0.03 . Revenue of $4.14M (+66.9% Y/Y) beats by $0.77M . U.S. revenue was $2.1 million in the first quarter of 2023 compared to $0.8 million in the prior year per...
Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today reported financial results for the quarter ended March 31, 2023. R...
2023-05-08 15:20:06 ET The basic definition of penny stocks includes shares of public companies priced under $5. While some traders might argue that they are exclusive to the Over-The-Counter or “OTC exchange,” the truth is that numerous low-priced stocks can also be found on ...
Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced that it plans to release its first quarter 2023 financial resul...
ASCENSIA DIABETES CARE MARKS ONE-YEAR ANNIVERSARY OF US EVERSENSE E3 CGM LAUNCH WITH COMMERCIAL UPDATE AND INNOVATION OUTLOOK PR Newswire PARSIPPANY, N.J. , April 24, 2023 /PRNewswire/ -- Ascensia Diabetes Care , a global diabetes care company, maker of the CONTOUR ...
Senseonics Holdings, Inc. (NYSE-American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced the first pediatric study participant has been inserted with E...
2023-04-06 17:02:12 ET The FDA on Thursday classified a recent product recall announced by Abbott Laboratories ( NYSE: ABT ) for millions of its FreeStyle Libre glucose monitoring systems as a Class I recall, the most serious type. The agency said that Abbott ( ABT ) began...
2023-03-26 12:00:27 ET The market for continuous glucose monitoring systems, where companies such as Abbott Laboratories ( ABT ) and DexCom ( NASDAQ: DXCM ) dominate, is expected to reach $31.7B by 2031, Allied Market Research said in a recent industry report. Rising dia...
News, Short Squeeze, Breakout and More Instantly...
Senseonics Holdings Inc. Company Name:
SENS Stock Symbol:
NYSE Market:
Senseonics Holdings Inc. Website:
Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced business updates and provided its full year 2024 financial out...
Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to host a business update and analyst event during the A...
Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to participate in the upcoming Sidoti Small Cap Conferen...